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Objectives: Alcoholism is one of the most devastating diseases with high incidence, but knowledge of its pathology and treatment
is still plagued with gaps mostly because of the inherent limitations of research with patients. We developed an animal model for
studying liver histopathology, Hsp (heat-shock protein)-chaperones involvement, and response to treatment.
Methods: The system was standardized using mice to which ethanol was orally administered alone or in combination with
Lactobacillus fermentum following a precise schedule over time and applying, at predetermined intervals, a battery of techniques
(histology, immunohistochemistry, western blotting, real-time PCR, immunoprecipitation, 3-nitrotyrosine labeling) to assess liver
pathology (e.g., steatosis, fibrosis), and Hsp60 and iNOS (inducible form of nitric oxide synthase) gene expression and protein
levels, and post-translational modifications.
Results: Typical ethanol-induced liver pathology occurred and the effect of the probiotic could be reliably monitored. Steatosis
score, iNOS levels, and nitrated proteins (e.g., Hsp60) decreased after probiotic intake.
Conclusions: We describe a mouse model useful for studying liver disease induced by chronic ethanol intake and for testing
pertinent therapeutic agents, e.g., probiotics. We tested L. fermentum, which reduced considerably ethanol-induced tissue
damage and deleterious post-translational modifications of the chaperone Hsp60. The model is available to test other agents and
probiotics with therapeutic potential in alcoholic liver disease.
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INTRODUCTION
Alcoholic liver disease (ALD) is caused by alcohol abuse and
occurs after years of excessive drinking. The pathogenesis is
characterized by progressive accumulation of lipids in the liver
(early steatosis), inflammation, steatohepatitis, and in some
individuals, the final stages include fibrosis and cirrhosis.1,2
Induction of oxidative and nitrosative stresses and activation of
the inflammatory cascade are implicated in the pathophysiol-
ogy of ALD.3,4 Oxidative stress includes cell and tissue
damages resulting from an imbalance between excessive
production of reactive oxygen species (ROS) and/or reactive
nitrogen species (RNS) and limited antioxidant defenses.
Mitochondria are the principal source of free radicals and
oxidative stress because of inefficiencies in the electron flow
along the electron transport chain.5,6 The liver is one of the
richest organs in mitochondria and, in hepatocytes, ROS may
have a role in nitric oxide (NO) synthesis and metabolism,
caspase activity, and DNA fragmentation.7 NO acts as a
messenger that modulates several cellular processes and is
described as a highly toxic and reactive molecule. Conversely,
it has also been demonstrated that NO is antiapoptotic in
hepatocytes and is required for normal liver regeneration.8,9
NO is enzymatically synthesized through NO synthase (NOS)
and liver contains diverse forms of NOS such as the neuronal
form (nNOS, NOS1) in the peribiliary plexus; the inducible form
(iNOS, NOS2) in hepatocytes, cholangiocytes, andKupffer and
stelate cells; and endothelial form (eNOS, NOS3) in the
endothelial cells.7 NO easily reacts with the superoxide anion,
producing the highly reactive peroxynitrite, and this can
produce novel products such as nitrotyrosine (NT), nitrotrypto-
phan, and nitrated lipids that serve as important biological
markers in vivo.10 Evaluation of NT levels, along with those of
NO, serves to monitor cell damage, as well as the degree of
inflammation in diseases associated with oxidative stress.11
Among the mediators of stress responses are heat-shock
proteins (Hsps), which are induced in the brain and liver by
acute and chronic alcohol administration.4,12 Hsps, many of
which are molecular chaperones, are ubiquitous and highly
conserved proteins constitutively expressed under normal
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temperature with indispensable functions in the life cycle of
proteins and with a role in protecting cells from deleterious
stressors. Molecular chaperones inhibit aggregation of par-
tially denatured proteins and refold them to maintain protein
homeostasis and tissue physiology.13,14 One member of the
Hsps is Hsp60, a molecular chaperone that assists protein
folding in mitochondria together with its cochaperone
Hsp10.15 Hsp60 is constitutively expressed under normal
conditions and induced by different types of stressors such as,
e.g., oxidative stress.16,17 In the liver, Hsp60 is involved in
hepatocellular carcinoma, chronic active hepatitis, and
primary biliary cirrhosis.14 Hsp60 has been considered a
major defence system against cellular damage after ethanol
administration in the liver and pancreas.18
The oxidative stress associated with ALD seems to be
caused not only by an increase in pro-oxidants but also via an
alteration in the oxidant–antioxidant tissue profile because of
poor nutrition or malabsorption in the gastrointestinal tract of
the alcoholics.19,20 The use of dietary supplements reduces
body fat mass and lowers cancer risk.21,22 Probiotics are living
microorganisms, usually bacteria that confer numerous
beneficial effects on the host’s health. Lactobacillus and
Bifidobacterium are the most common types of microbes used
as probiotics, but strains of Bacillus, Pediococcus, and some
yeast have also been found as suitable candidates. These
microorganisms are part of the normal intestinal microbial flora
and are ingested with fermented food with added active live
cultures, e.g., yogurt, and other dietary supplements.23
Encouraging results have been reported on the use of
probiotics in the treatment of various disorders such as
pouchitis,24 ulcerative colitis,25,26 and Crohn's disease.27
Other studies have shown hypolipidemic and antioxidant
properties of a probiotic mixture in hyperlipidemic hamsters.28
There is evidence for the roles played by commensal bacteria
in alcohol-induced liver injury through dysbiosis of the
intestinal microbial ecosystem caused by alcohol intake.29
Despite the importance of alcoholism and its devastating
personal and social impact, with disastrous economic
consequences, and despite the great number of studies
carried out to understand its pathophysiology and to develop
effective therapies, there are still many aspects of this disease
that are incompletely understood. One reason for this knowl-
edge gap is that the clinicopathological research and trials of
novel therapeutic agents with human patients are extremely
limited. It is therefore cogent to develop animal models
amenable to histopathological and molecular studies focused
on the organs most affected by the disease, for instance, the
liver and brain, and that would allow trials of potentially
curative agents. In this work, we have standardized a model
system using mice, and have focused on the liver and the
molecular chaperone Hsp60. In addition, we have tested the
effects of a probiotic, Lactobacillus fermentum, on the
alterations we found in the mice fed with ethanol in their diet.
METHODS
The model system: animals and diets. All animal experi-
ments were approved by the ethics committee for animal
experiments at the University of Palermo and adhered to the
recommendations in the guide for the care and use of labo-
ratory animals set by the National Institutes of Health (NIH,
Bethesda, MD). Moreover, all experiments were performed in
the Human Physiology Laboratory of the Department of
Experimental Biomedicine and Clinical Neuroscience at the
University of Palermo, which was formally authorized by the
Ministero della Sanità (Rome, Italy).
The study reported here to standardize and calibrate the
mouse model was performed with female 12-month-old mice
(BALB/cAnNHsd) obtained from Harlan laboratories S.r.l.
(Udine, Italy) (Table 1). The animals were kept at a constant
12 : 12 h light–dark cycle and had free access to food (4RF21
standard diet, Mucedola; Settimo Milanese, Milan, Italy) and
water, which was the diet for the control (Con) mice (n= 13).
For the experimental mice, ethanol 96% (EtOH) (Girolamo
Luxardo, Torrella, Padova, Italy) was added to account for 15%
of total calories. To allow for acclimation to the alcohol diet, the
animals were given 5%EtOH-calorie content for 2 days, which
was increased to 10% EtOH-calorie content for 2 days,
followed by 15% EtOH-calorie content diet30,31 for 4 (mouse
group 4EtOH, n=5), 8 (mouse group 8EtOH, n=5), and 12
(mouse group 12EtOH, n= 5) weeks. A calculation to increase
the standard caloric need of the mice (14 kcal per day, 3.6 g of
their food) with the addition of EtOHwasmade considering the
caloric content of EtOH diluting it in water in a final volume of
100 μl. This volume was orally administered to the mice every
day using a pipette. Three additional mouse groups were
added: 4EtOH-P (ethanol and probiotic diet), 8EtOH-P, and
12EtOH-P (n= 5 per group). These mice were given EtOH
as the others (groups 4EtOH, 8EtOH, and 12EtOH), but they
also received orally, using a pipette, L. fermentum probiotic
(Bromatech S.r.l., Milan, Italy), 109 CFU (colony-forming unit)
per animal in water, each day during the week, with two days
off on weekends, until the end of the experiment. The probiotic
was given 20 min after the EtOH administration to investigate
its efficacy to counteract the deleterious effects of ethanol on
the liver. One more group received the ethanol-containing diet
for 8 weeks and then the probiotic for 4 weeks (group
8EtOH-4P, n= 5), as a pilot study to investigate the curative
effects of the probiotic on the liver steatosis and oxidative
stress induced by the preceding ethanol consumption. Food
and water intake were measured every day, and body weight
was measured three times weekly. The diet was controlled
weighing the food to adjust it to the daily caloric needs of the
mice. Mice were killed 48 h following the last treatment.
Histopathology. Liver tissue from the same hepatic lobe of
all mice was excised from EtOH, EtOH-P, and Con mice, fixed
in 10% buffered formalin, and embedded in paraffin as
described previously.32 Thin sections, obtained from paraffin
blocks, were stained with hematoxylin–eosin for histological
evaluation of liver injury and Masson's trichrome stain was
performed for evaluation of liver fibrosis.33 Slides were
examined, and images captured under bright field with a
Leica DM5000 upright microscope (Leica Microsystems,
Heidelberg, Germany). Liver sections were examined
by two expert pathologists in a blind manner, using coded
slides and not knowing their source. The mean of the
results was used as data. Liver steatosis was classified
using a semiquantitative scoring system divided into three fat
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grades (grade I=5–33%; grade II=34–66%; and grade
III=67–100%).34
Analysis of serum. The animals were killed by decapitation
for blood collection. The serum was separated by centrifuga-
tion with 3000 g at 4 °C for 10 min and then stored at −20 °C.
Serum aspartate transaminase (AST) and alanine transami-
nase (ALT) were measured by clinical laboratories of the
University of Palermo using an in vitro test (Modular
Analytics; Roche, Vienna, Austria) for the quantitative
determination of the two enzymes in serum on Roche
automated clinical chemistry analyzer (Roche/Hitachi
Modular; Roche).
Real-time quantitative PCR. The quantitative real time PCR
(qRT-PCR) technique was performed as described
previously.35,36 Briefly, total RNA was isolated from 300 mg
of the liver from Con and experimental mice using TRIzol
REAGENT (Sigma-Aldrich, Milan, Italy), according to the
manufacturer’s instructions. RNA (50 ng) was retro-
transcribed using the ImProm-II Reverse Transcriptase Kit
(Promega, Milan, Italy) to obtain cDNA, which was amplified
using the StepOnePlus Real-Time PCR System (Life
Technologies, Monza, Italy). Quantitative Real-Time PCR
(qRT-PCR) was performed using GoTaq qPCR Master Mix
(A6001; Promega). The mRNA levels were normalized to the
levels obtained for hypoxanthine phosphoribosyltransferase
1, for β-glucuronidase, and for glyceraldehyde-3-phosphate
dehydrogenase. The cDNA was amplified using the primers
indicated in Supplementary Table S1 online and the Rotor-
gene 6000 Real-Time PCR Machine (Qiagen GmbH, Hilden,
Germany). Changes in the transcript level were calculated
using the 2–ΔΔCT method.37
Western blotting. Western blotting was performed as
described previously.38 Equal amounts of protein (40 μg)
were separated on sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and transferred onto a nitrocellulose
membrane (BioRad, Segrate, Italy). After blocking with 5%
bovine serum albumin (Sigma-Aldrich), membranes were
probed with primary antibodies as follows: mouse anti-Hsp60
monoclonal antibody, LK1 clone (Sigma-Aldrich), dilution
1 : 1000; rabbit polyclonal to iNOS (GeneTex, Irvine, CA),
dilution 1 : 2000; mouse anti-β-actin monoclonal antibody
(Sigma-Aldrich) diluted at 1 : 1000; by overnight incubation at
4 °C. Protein bands were visualized using the enhanced
chemiluminescence detection system (GE Healthcare Life
Sciences, Milan, Italy), and the data were evaluated and
quantified using the ImageJ Free software (NIH). Each
experiment was performed at least three times.
Immunoprecipitation. To detect Hsp60 protein nitration,
immunoprecipitation was performed. Briefly, equal amounts
of protein (500 μg) from total liver tissue lysates from each
mouse group (experimental and Con) were incubated with
the primary antibody (mouse monoclonal anti-Hsp60, Clone
LK1; Sigma-Aldrich) overnight at 4 °C with gentle rotation.
Antibody–protein complexes were then immunoprecipitated
with antibodies linked to Sepharose G beads (GE Healthcare,
Milano, Italy). Nonspecifically bound proteins were removedTa
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by repeated washings with isotonic lysis buffer. Immunopre-
cipitated proteins were resolved by 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and revealed
using anti-3-NT primary antibodies (mouse monoclonal to
3-NT; Abcam, San Francisco, CA; dilution 1 : 1400). Each
experiment was performed at least three times.
Immunohistochemistry. Immunohistochemistry was per-
formed as described previously.39 Liver sections (5 μm) were
mounted on glass slides and deparaffinized. Sections were
immersed in 0.3% H2O2 for 5 min to quench endogenous
peroxidase activity, and treated with 10 mM, pH 6.0, 0.05%
Tween-20 tri-sodium citrate at 75 °C for 8 min for antigen
retrieval. Subsequently, immunohistochemistry was per-
formed using the Histostain-Pluss IHC detection Kit (Histos-
tain-plus Kit3rd Gen IHC Detection Kit; Life Technologies,
Monza, Italy) and primary antibodies against the inducible
form of NOS (iNOS) (rabbit polyclonal to iNOS, GeneTex;
dilution 1 : 200); 3-NT (mouse monoclonal to 3-NT; Abcam;
dilution 1 : 200); and Hsp60 (mouse monoclonal antibody,
LK1 clone; Sigma-Aldrich). Nuclear counterstaining was
carried out using hematoxylin (Dako, Carpinteria, CA). The
immunostained tissue sections were examined at x400 and
analyzed in a blind manner, using coded slides and not
knowing their source. Data from each tissue section (10 fields
per section) were pooled to determine mean values, as
described previously.40
Statistical analysis. Statistical analyses were performed
using the package GraphPad Prism 4.0 software (GraphPad
Prism Software, San Diego, CA). The data obtained for body
weight, food and water intake within the groups were
compared by one-way analysis of variance for repeated
measurements, whereas all the other data were analyzed
between the groups (Con vs. all; 4EtOH vs. 4EtOH-P, 8EtOH,
and 12EtOH; 8EtOH vs. 8EtOH-P, 12EtOH; 12EtOH vs.
12EtOH-P and 8EtOH-4P) via one-way analysis of variance.
If a significant difference was detected by the analysis of
variance analyses, this was further evaluated by Bonferroni
post hoc test. The data were expressed as means± s.d. The
statistical significance threshold was fixed at the level of
Po0.05.
RESULTS
Effects of ethanol consumption and L. fermentum
administration on hepatic steatosis. The data obtained
for body weight, food and water intake did not show signifi-
cant differences within and between the groups (Supple-
mentary Tables S2, S3, and S4 online). Liver sections,
stained with hematoxylin–eosin and Masson's trichrome,
were observed with an optical microscope, for histological
evaluation of ALD. For this evaluation, we considered four
histological features: steatosis, inflammation, hepatocellular
injury, and fibrosis. As seen in the photomicrographs
presented in Figure 1a, there was no apparent evidence of
inflammation or necrosis in the EtOH-fed mice compared with
the Con mice. The stain revealed a temporal increase in
hepatic steatosis in EtOH-fed mice compared with Con mice.
The hematoxylin- and eosin-stained liver sections showed
well-defined vacuolated areas in the hepatocytes in 8EtOH
and 12EtOH mice, persisting also after 8EtOH-4P. In the
8EtOH and 12EtOH groups, steatosis of grade II and grade
III, respectively, was present, whereas in the 4EtOH mice no
sign of liver steatosis was observed. L. fermentum adminis-
tration 20 min after EtOH consumption reduced liver stea-
tosis. Liver sections from the 8EtOH-P and 12EtOH-P groups
showed liver steatosis of grade I, whereas the 8EtOH-4P
group showed a liver steatosis of grade II, namely lower
degrees of steatosis compared with the matched groups not
receiving the probiotic. The liver steatosis score increased
significantly in 8EtOH and 12EtOH-fed mice compared with
the Con and 4EtOH (Po0.001); the score was also
significantly higher in 12EtOH compared with 8EtOH-fed
mice (Po0.001) (Figure 1b, EtOH groups). In EtOH-P
groups, liver steatosis score increased significantly in
8EtOH-P and 12EtOH-P mice compared with the Con and
4EtOH-P (Po0.001); the score was also significantly higher
in 12EtOH-P compared with 8EtOH-P (Po0.001) and in
8EtOH-4P compared with Con and 12EtOH-P (Po0.001)
(Figure 1b, EtOH-P groups). Liver steatosis decreased
significantly in 8EtOH-P compared with 8EtOH (Po0.001),
as well as in 12EtOH-P and 8EtOH-4P compared with
12EtOH (Po0.001) (Figure 1b, EtOH/EtOH-P groups). The
trichrome stain showed the absence of fibrosis in all speci-
mens (see Supplementary Figure S1 online). Collagen was
present only in the portal space and, in limited amounts, in
perisinusoidal (Disse) spaces of the lobule in all liver
samples.
Effects of L. fermentum administration on AST and ALT
levels. The degree of liver injury by the alcohol was
evaluated by measuring the content of liver enzymes AST
and ALT in the serum (Figure 2a). The serum AST levels
(Figure 2a) were significantly increased in 12EtOH compared
with the Con, 4EtOH, 8EtOH, 12EtOH-P, and 8EtOH-4P
groups (Po0.001). The histogram also shows an increase of
AST levels in 12EtOH-P compared with the Con, 4EtOH-P,
and 8EtOH-P fed groups. A significant increase was also
apparent in 8EtOH-4P compared with the Con group
(Figure 2a). The ALT levels (Figure 2b) significantly increased
in all the groups compared with the Con group and in 12EtOH
compared with 4EtOH and 8EtOH (Po0.05). Moreover, there
was an increase of the enzyme levels in 8EtOH-4P compared
with 12EtOH-P (Po0.001).
Effects of ethanol consumption and L. fermentum
administration on iNOS and 3-NT levels. NO-derived
pro-oxidants iNOS protein expression was evaluated as a
marker of hepatic dysfunction and cytotoxicity because of
chronic exposure to EtOH. As shown in Figure 3a, the iNOS
gene expression levels did not change in the EtOH/EtOH-P
groups as compared with the control group. Western blotting
showed that EtOH consumption increased the levels of iNOS
protein after 8 and 12 weeks compared with control and
4EtOH mice (Figure 3b,c Po0.01). iNOS levels decreased
significantly in 12EtOH-P and in 8EtOH-4P compared with
12EtOH-fed group (Figure 3b,c) (Po0.01). iNOS immunor-
eactivity was detected in control liver sections, confirming
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that the protein was constitutively present in hepatocytes
(Figure 4a). Cellular localization for iNOS was both cytoplas-
mic and nuclear in sections derived from the liver of EtOH-fed
mice. Tissue levels of iNOS increased in all treated mice
groups compared with the Con group, and the increase
was statistically significant (Po0.001) (Figure 4b). iNOS
immunoreactivity decreased in 4EtOH-P compared with
4EtOH (Po0.01) and in 8EtOH-4P compared with 12EtOH
(Po0.001).
Hepatic nitrosative stress was evaluated by immunohisto-
chemical staining of 3-NT indicating peroxynitrite-dependent
nitration of protein tyrosine residues. As shown in Figure 5a,
3-NT immunoreactivity increased in the EtOH-fed groups
and its distribution was both cytoplasmic and nuclear. The
semiquantitative analysis revealed that the increase
was statistically significant for all treated animal groups
compared with the Con group (Po0.001) (Figure 5b). The
histogram shows a significant decrease of 3-NT immuno-
reactivity in 8EtOH-P compared with 4EtOH-P, 8EtOH, or
12EtOH-P (Po0.001). A significant increase was also
registered in 12EtOH compared with 8EtOH and 8EtOH-4P
(Po0.05).
Effects of ethanol consumption and L. fermentum
administration on hsp60 gene expression and protein
levels. As EtOH consumption causes mitochondrial dys-
function and protein nitration in the liver, hsp60 gene
expression, Hsp60 protein levels, and tissue distribution were
evaluated using qRT-PCR, western blotting, and immunohis-
tochemistry. As shown in Figure 6a, expression of the hsp60
Figure 1 Representative photomicrographs of liver sections stained with hematoxylin–eosin. (a) Liver histology of mice fed control (Con), ethanol (EtOH) diets, and ethanol
and probiotic diet (EtOH-P). Bar= 100 μm for all panels. (b) Histogram representing the degree of hepatic steatosis as determined by severity scores from I to III. The score is
represented as percentage of steatosis (grade I= 5–33%; grade II= 34–66%; grade III= 67–100%). Results are expressed as mean± s.d. In b, the horizontal lines on top of the
histograms indicate a significant difference within the groups (Po0.001). For further explanation of abbreviations and model features see Table 1. AU, arbitrary unit; 4EtOH,
ethanol-fed mice for 4 weeks; 8EtOH, ethanol-fed mice for 8 weeks; 12EtOH, ethanol-fed mice for 12 weeks; 4EtOH-P, ethanol and probiotic-fed mice for 4 weeks; 8EtOH-P,
ethanol and probiotic-fed mice for 8 weeks; 12EtOH-P, ethanol and probiotic-fed mice for 12 weeks; 8EtOH-4P, ethanol-fed mice for 8 weeks and then given probiotic for 4 weeks;
wks, weeks.
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gene in the liver was upregulated in 4EtOH-P- and 8EtOH-fed
mice compared with the control group (Po0.01), and in
4EtOH-P compared with 12EtOH-P (Po0.05). Western
blotting analysis showed that the Hsp60 protein levels
significantly increased in the 8EtOH group as compared with
the Con and 4EtOH groups, and in the 8EtOH-P group
compared with Con and to 4EtOH-P groups (Po0.05; Figure
6b,c). Immunohistochemical staining for Hsp60 revealed that
there were low levels of the chaperonin protein in hepato-
cytes from control mice and, in contrast, these levels
increased with the increase in alcohol consumption
(Figure 7a). Conversely, high Hsp60 levels were present in
the 8EtOH-P mice, but the proteins level decreased after
12 weeks of alcohol consumption alone or in combination
with the probiotic (Figure 7a). The semiquantitative analysis
showed that Hsp60 levels in the liver tissue significantly
increased in all treated mice groups (except for 4EtOH)
compared with the Con group. Hsp60 immunoreactivity also
increased significantly in 12EtOH compared with 4EtOH
(Po0.01) (Figure 7b). Similarly, the increase of the protein
levels was significant in 8EtOH-P compared with 4EtOH-P
and 12EtOH-P (Po0.05).
Double-labeled immunoprecipitation of 3-NT and the
chaperonin revealed that the quantity of nitrated Hsp60
significantly increased in 12EtOH-fed mice compared with
8EtOH but in contrast nitrated Hsp60 decreased in 12EtOH-P
compared with 12EtOH (Figure 8).
DISCUSSION
Many studies have attempted to identify the molecular
pathways affected directly or indirectly by alcohol in the liver.
These pathways range from oxidative stress, metabolism-
related phenomena, and inflammation to apoptosis. Key
events for the onset and progression of ALD result, in part,
from gut–liver interaction.29,41 Consumption of large quantities
of alcoholic beverages leads to disturbances in the intestinal
absorption of sodium, water, and nutrients, which contributes
to the tendency in alcoholics to develop diarrhea. Further-
more, alcohol abuse can result in duodenal erosions, bleeding
and mucosal injury in the upper jejunum.42 Commensal
bacteria have a fundamental role in alcohol-induced liver
Figure 3 Inducible form of NOS (iNOS) levels in the liver of control (Con) and
ethanol (EtOH) fed mice. (a) The bars indicate the degree of the iNOS gene
expression normalized for the reference genes, according to the Livak method
(2−ΔΔCT), in the liver of control (Con), ethanol diets, and ethanol and probiotic diet
mice. (b) Ratio iNOS levels/β-actin levels as a reflection of iNOS increase and
decrease (mean± s.d.). One-way analysis of variance, Bonferroni post hoc test. (c)
Representative cropped blots for iNOS in Con and EtOH-fed mice. The gels were run
under the same experimental conditions and β-actin was used as an internal control.
*Po0.01 vs. 8EtOH and 12EtOH; #Po0.01 vs. 4EtOH; ΔPo0.01 vs. 4EtOH,
12EtOH-P, and 8EtOH-4P. For the meaning of the abbreviations in a and b, indicating
each mouse group, see legend for Figure 1 and Table 1. AU, arbitrary unit; Con,
control; 4EtOH, ethanol-fed mice for 4 weeks; 8EtOH, ethanol-fed mice for 8 weeks;
12EtOH, ethanol-fed mice for 12 weeks; 4EtOH-P, ethanol and probiotic-fed mice for
4 weeks; 8EtOH-P, ethanol and probiotic-fed mice for 8 weeks; 12EtOH-P, ethanol and
probiotic-fed mice for 12 weeks; 8EtOH-4P, ethanol-fed mice for 8 weeks and then
given probiotic for 4 weeks.
Figure 2 Aspartate transaminase (AST) and alanine transaminase (ALT) levels
in the serum of mice. Histograms showing (a) ASTand (b) ALT levels. Each value is
expressed as mean± s.d. *Po0.001 vs. Con, 4EtOH, 8EtOH, 12EtOH-P, and
8EtOH-4P; ◊Po0.001 vs. Con, 4EtOH-P, and 8EtOH-P; #Po0.001 vs. Con;
§Po0.001 vs. all other groups; ¥Po0.05 vs. 4EtOH and 8EtOH; +Po0.001 vs.
12EtOH-P. For the meaning of the abbreviations in a and b, indicating each mouse
group, see legend for Figure 1 and Table 1. Con, control; 4EtOH, ethanol-fed mice for
4 weeks; 8EtOH, ethanol-fed mice for 8 weeks; 12EtOH, ethanol-fed mice for
12 weeks; 4EtOH-P, ethanol and probiotic-fed mice for 4 weeks; 8EtOH-P, ethanol and
probiotic-fed mice for 8 weeks; 12EtOH-P, ethanol and probiotic-fed mice for
12 weeks; 8EtOH-4P, ethanol-fed mice for 8 weeks and then given probiotic for
4 weeks.
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injury through the shift of the composition of the gut microbiota
(dysbiosis) caused by alcohol intake.29 The gut is a habitat for
billions of microorganisms and the gut mucosal epithelium
serves as a barrier between microbiota and gut tissue.43
Alcohol abuse not only causes gut leakiness but also affects
the composition of colonic mucosa-associated bacterial
microbiota in alcohol-fed rats.44 Moreover, there is evidence
of Gram-negative bacterial overgrowth in the gut of
alcoholics.42 Alcohol or its metabolites, e.g. acetaldehyde,45
disrupt the intestinal barrier and increase gut permeability by
various mechanisms such as increased ROS46 and iNOS47
and alteration of microRNAs.48 The disruption of the intestinal
barrier causes bacterial and endotoxins translocation in the
portal circulation, leading to liver dysfunction, inflammation,
fibrosis, and steatosis.41 It is, therefore, reasonable to
hypothesize that the restoration of normal intestinal flora
may be of help in the treatment of ALD. In this regard, animal
experiments have demonstrated that attenuation of ethanol-
induced intestinal permeability, endotoxemia, and liver injury
can be achieved using antibiotics, dietary supplements, and
probiotics.49 However, it is necessary to point out that the
microbiota in mice is different from that of humans; none-
theless,mice have become themodel of choice and a powerful
tool for most studies in the emerging field of human gut
Figure 4 Hepatocellular distribution of the inducible form of NOS (iNOS). (a) Representative photomicrographs of liver sections immunohistochemically stained for iNOS
showing iNOS distribution both in the nucleus and the cytoplasm of hepatocytes. Strong staining for iNOS was present in the liver cells after 4, 8, and 12 weeks of alcohol intake,
but when alcohol intake was accompanied with the probiotic, the staining intensity decreased. Bar= 100 μm for all panels. (b) Histogram showing the percentages of hepatocytes
positive for iNOS. The analysis was conducted in a blind manner (using coded slides with the observer not knowing the source of them) and the results are expressed as
mean± s.d. *Po0.001 vs. all other groups; §Po0.01 vs. 4EtOH-P; ¥ Po0.001 vs. 8EtOH-4P. For the meaning of the abbreviations in a and b, indicating each mouse group, see
legend for Figure 1 and Table 1. Con, control; 4EtOH, ethanol-fed mice for 4 weeks; 8EtOH, ethanol-fed mice for 8 weeks; 12EtOH, ethanol-fed mice for 12 weeks; 4EtOH-P,
ethanol and probiotic-fed mice for 4 weeks; 8EtOH-P, ethanol and probiotic-fed mice for 8 weeks; 12EtOH-P, ethanol and probiotic-fed mice for 12 weeks; 8EtOH-4P, ethanol-fed
mice for 8 weeks and then given probiotic for 4 weeks; wks, weeks.
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microbiota, owing to its association with a wide range of
diseases such as obesity, type 2 diabetes, inflammatory bowel
disease, and the diseases caused by alcohol abuse.50
Our results show that, in mice, chronic alcohol feeding leads
to a significant increase of liver steatosis classified as grade II
in 8EtOH and grade III in 12EtOH. Counterparts fed with the
probiotic showed a significant decrease of alcohol-induced
liver steatosis from grade II and III to grade I. These findings
are consistent with studies showing a correlation between
dietary supplementation with probiotics and lipid metabolisms
and reduction of fat accumulation in the liver.51,52 Liver
damage was marked at 12 weeks of EtOH administration
and the probiotic had the capacity to protect against the
pathogenic alcohol effects as indicated by a decrease in the
levels of AST. Similarly, serum ALT levels were significantly
higher at 12 weeks of EtOH administration compared with the
other groups and, although there was a significant increase
after 4 and 8 weeks, the reduction occurred only after a
prolonged exposure to the probiotic.
Other authors have used mice to evaluate the effects of
protein nitration in acute and chronic liver diseases.53 In
alcohol-exposed wild-type mice, the expression of iNOS was
proportional to the levels of hepatic nitration and inhibition of
mitochondrial function, whereas the iNOS(− /− ) mice showed
Figure 5 Levels of nitrotyrosine-positive cells in liver sections. (a) Representative photomicrographs of 3-nitrotyrosine (3-NT) immunoreactivity. Alcohol intake induced
oxidative stress and protein nitration, while simultaneous intake of alcohol and the probiotic for 8 weeks reduced this effect. Bar= 100 μm for all panels. (b) Histogram showing the
percentages of hepatocytes positive to 3-NT in the various groups studied. The analysis was conducted in a blind manner (using coded slides with the observer not knowing the
source of them). *Po0.001 vs. all other groups; Δ Po0.001 vs. 4EtOH-P, 8EtOH, and 12EtOH-P; #Po0.05 vs. 8EtOH, 8EtOH-4P. For the meaning of the abbreviations in a and
b, indicating each mouse group, see legend for Figure 1 and Table 1. Con, control; 4EtOH, ethanol-fed mice for 4 weeks; 8EtOH, ethanol-fed mice for 8 weeks; 12EtOH, ethanol-
fed mice for 12 weeks; 4EtOH-P, ethanol and probiotic-fed mice for 4 weeks; 8EtOH-P, ethanol and probiotic-fed mice for 8 weeks; 12EtOH-P, ethanol and probiotic-fed mice for
12 weeks; 8EtOH-4P, ethanol-fed mice for 8 weeks and then given probiotic for 4 weeks; wks, weeks.
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decreased levels of nitrated proteins and more resistance to
alcoholic fatty liver disease.54 Moreover, ethanol-induced
production of NO via induction of iNOS increased the liver
susceptibility to hypoxia and induced depression of mitochon-
drial energy state, leading to energy depletion and, ultimately,
to the development of alcohol-mediated hepatic injury.55 In our
experiments, iNOS gene expression did not change after
EtOH administration, which may be a reflection of post-
transcriptional regulation of this enzyme. Western blotting
showed that EtOH consumption increased iNOS levels in all
EtOH-fed mouse groups in accordance with other studies in
which levels of iNOS were increased following the exposure to
EtOH.56,57 The increase reached high levels after 8 and
12 weeks of EtOH administration, whereas a decrease of
iNOS levels was observed in 12EtOH-P and in 8EtOH-4P
compared with 12EtOH group. These data were confirmed
by the analysis of the distribution of iNOS immunoreactivity.
L. fermentum reduced significantly iNOS levels in the liver,
confirming that this lactic acid bacterium has the capacity to
decrease the toxic effect of alcohol as previously described.58
The combination of NO and superoxide produces peroxyni-
trite, which is known to be an important mediator in various
pathological conditions, including liver diseases. Peroxynitrite
can modify tyrosine (Tyr) residue(s) of many proteins in
different cell compartments resulting in protein nitration, which
alters their structure and function.53 In our study, 3-NT
immunoreactivity increased significantly in EtOH-fed mice
and its distribution was both cytoplasmic and nuclear. It
has been reported that protein nitration has an important
role in promoting the ethanol-mediated mitochondrial dysfunc-
tion, hepatic toxicity, and intestinal barrier dysfunction.59
L. fermentum reduced 3-NT levels in 8EtOH-P and in
8EtOH-4P compared with 8EtOH and 12EtOH, respectively.
Moreover, in 8EtOH-P mice, 3-NT decreased significantly
compared with all the probiotic-fed mouse groups. In this
regard, relevant to our findings, it has been shown that
L. fermentum has antioxidant properties in as much as it
reduced lipid peroxidation and enhanced the antioxidant
activity of glutathione peroxidase and glutathione
reductase.60–62
As Hsps have a role in the protection of many cellular
components during alcohol stress,63 we focused on the
mitochondrial chaperonin Hsp60 and its gene’s expression
levels by measuring mRNA as well as the levels of the gene’s
product by quantifying Hsp60 protein in liver tissue. The data
showed that hsp60 gene expression and the levels of Hsp60
protein levels were elevated in 8EtOHmouse group compared
with the control group, and in 8EtOH-P compared with 4EtOH-
P. Immunohistochemical staining revealed that Hsp60 immu-
noreactivity increased with the increase of alcohol intake, but it
decreased after 12 weeks of alcohol consumption alone or in
combination with the probiotic. Hsp60 increase in the liver of
8EtOH-fed mice may be considered as a protective mechan-
ism against oxidative stress to maintain tissue homeostasis.
After 12 weeks of ethanol administration, mitochondrial dys-
function likely leads to a reduction in hsp60 gene expression
and in the levels of Hsp60 protein. One of the cytoprotective
effects of Hsps is related to their ability to inhibit apoptosis.
Hsp60 forms a complex with procaspase-3 and displays an
antiapoptotic effect.64 In cardiac myocytes, Hsp60 has an
antiapoptotic role by forming a macromolecular complex with
Bax and Bak and, thereby, blocking their ability to induce
apoptosis.65 Thus, reduced levels of Hsp60 may exacerbate
ALD as more Bax and Bak are released in response to
alcohol-induced stress.66 The increase of oxidative stress is
due, in part, to impaired folding of the manganese superoxide
dismutase, a key endogenous antioxidant enzyme. It has been
demonstrated that Hsp60 and manganese superoxide dis-
mutase proteins interact because manganese superoxide
dismutase is a substrate of the Hsp60 folding machinery.67
Hsp60 specifically associates with mitochondrial ATP
synthase, the enzyme necessary to produce and hydrolyze
ATP, protecting ATP synthase from degradation.68 Therefore,
Hsp60 participates in themaintenance of the balance between
oxidants and antioxidants in ALD.
As stated above, protein nitration in chronic and acute liver
diseases may result in structural and functional alterations of
each target protein, as for example the loss of the catalytic
activity if the target protein is an enzyme.53 In our experiments,
chronic EtOH intake significantly increased Hsp60 nitration,
Figure 6 hsp60 gene expression and Hsp60 protein levels in the liver. (a) The
bars show the levels of hsp60 gene expression normalized for the reference genes,
according to the Livak method (2−ΔΔCT), in the liver of control (Con), ethanol diets,
and ethanol and probiotic diet mice. (b) Western blotting results. Ratio Hsp60 levels/
β-actin levels as a reflection of Hsp60 increase (mean± s.d.). (c) Representative
cropped western blots for Hsp60 in control and ethanol-fed mice. All gels were run
under the same experimental conditions and β-actin was used as an internal control.
*Po0.01 vs. 4EtOH-P, 8EtOH; #Po0.05 vs. 12EtOH-P; §Po0.05 vs. Con and
4EtOH; ¥ Po0.05 vs. Con, 4EtOH-P. For the meaning of the abbreviations in a and b,
indicating each mouse group, see legend for Figure 1 and Table 1. AU, arbitrary unit;
Con, control; 4EtOH, ethanol-fed mice for 4 weeks; 8EtOH, ethanol-fed mice for
8 weeks; 12EtOH, ethanol-fed mice for 12 weeks; 4EtOH-P, ethanol and probiotic-fed
mice for 4 weeks; 8EtOH-P, ethanol and probiotic-fed mice for 8 weeks; 12EtOH-P,
ethanol and probiotic-fed mice for 12 weeks; 8EtOH-4P, ethanol-fed mice for 8 weeks
and then given probiotic for 4 weeks; wks, weeks.
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and after 12 weeks of L. fermentum and EtOH consumption,
Hsp60 nitration decreased, suggesting a protective role of the
probiotic against nitrosative stress. Recent studies demon-
strated that Hsp60 nitration in hyperglycemia not only causes
a significant decrease in the ATP hydrolysis rate but also
altered the interaction of the protein with its cochaperone
Hsp10, impairing Hsp60 folding activity.69 In fact, the nitration
occurred in the hydrophobic position Y222 and Y226 in
the apical domain of the chaperonin, a domain crucial
for cochaperone and substrate binding of Hsp60.14,69 Then,
altered mitochondrial protein folding because of Hsp60/Hsp10
dysfunction or defective substrate binding could alter mito-
chondrial functionality, leading to the perpetuation of liver
injury.
Therefore, our study showed that oral intake of L. fermentum
protects against alcohol-induced liver injury in mice.
The cellular and molecular mechanisms involved in this
protection remain to be elucidated. ALD pathogenesis
requires endotoxemia, and increased intestinal permeability
is the major cause of endotoxemia. This gut leakiness is
dependent on alcohol stimulation of iNOS in both alcoholic
subjects and rodent models of alcoholic steatohepatitis.
L. fermentum might cause the liver-protective effects by
preventing endotoxemia by improving the intestinal barrier
function like other strains do, and/or by enhancing the
antioxidant activity of glutathione peroxidase and gluta-
thione reductase.60–62,70 The probiotic tested could decrease
iNOS levels and ameliorate the inflammation because
Figure 7 Levels and preferential localization of Hsp60 in control and ethanol-fed mice. (a) Liver sections stained with a monoclonal antibody specific for Hp60. Bar= 100 μm
for all panels. (b) Histogram showing the percentages of hepatocytes positive to Hsp60. The analysis was conducted in a blind manner (using coded slides with the observer not
knowing the source of them). *Po0.001 vs. all other groups (except for 4EtOH); ΔPo0.001 vs. 4EtOH; §Po0.05 vs. 4EtOH-P and 12EtOH-P. For the meaning of the
abbreviations in a and b, indicating each mouse group, see legend for Figure 1 and Table 1. Con, Control; 4EtOH, ethanol-fed mice for 4 weeks; 8EtOH, ethanol-fed mice for
8 weeks; 12EtOH, ethanol-fed mice for 12 weeks; 4EtOH-P, ethanol and probiotic-fed mice for 4 weeks; 8EtOH-P, ethanol and probiotic-fed mice for 8 weeks; 12EtOH-P, ethanol
and probiotic-fed mice for 12 weeks; 8EtOH-4P, ethanol-fed mice for 8 weeks and then given probiotic for 4 weeks; wks, weeks.
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of its capacity to modulate nuclear factor-κB and tumor
necrosis factor-α expression.71,72 Also, L. fermentum admin-
istration in mice can induce significant shifts in the indi-
genous microbial community,73 probably to a less toxic
composition.
A major concern for the use of probiotics in vivo is that
they must survive and sustain transit through the extreme
conditions of the gastrointestinal tract in large quantities to
allow their colonization in the host, and thus bring about the
expected benefits. A solution to this problem may be achieved
by developing encapsulation techniques to ensure greater
survival of probiotic bacteria in the stomach and intestine.
These techniques aim at protecting bacteria from detrimental
factors such as high acidity (low pH) or bile salts.74 However,
one may assume that the probiotic tested has a gut-protective
effect and, possibly, antisteatotic and antioxidant effects in the
liver. Our results provide novel insights, especially regarding
Hsp60, that may be taken into account while devising new
approaches for treating liver diseases associated with alcohol
consumption. These therapeutic strategies could be useful
in developing countries, in which efficacious treatment of
ethanol-related diseaseswill have a significant socioeconomic
impact as it might go a long way to resolve an important
health-related problem with a very simple and affordable
approach.
Other mouse models have been used to study alcoholic
liver injury but have limitations and disadvantages, such
as a relatively high mouse mortality, the need of extensive
medical care throughout the experiments and of a technically
challenging surgery that is difficult to perform in most
laboratories, and the induction of only a mild elevation of
ALTandmild liver fibrotic changes.75–78We have standardized
a mouse model (Table 1) different from other existing models
in various ways, mainly alcohol feeding modality, and use of
Hsp60 (a molecule that is central to vital cellular processes
directly affected by ethanol) as a key biomarker and of a
probiotic as a response monitor. This model is useful
for studying liver disease induced by protracted intake of
ethanol and for testing pertinent therapeutic agents, probiotics
in particular. In our model, ethanol was administered
without anesthesia using a noninvasive technique avoiding
mouse mortality and the use of potentially harmful surgical
techniques. These qualities ensure reproducibility and
facilitate the use of the model also in other laboratories. From
a pathological point of view, our model clearly reveals
elevation in serum ALT and AST levels (two- and threefold at
12 weeks compared with the Con), liver steatosis (after 8 and
12 weeks of alcohol feeding), and in induction of oxidative
and nitrosative stresses. Liver fibrotic changes and inflamma-
tion were not analyzed in depth and we did not carry out
measurements of the pertinent indicators, such as inflamma-
tory cytokines.
We have tested L. fermentum as response indicator and
found that it produced clear benefits in as much as it reduced
considerably ethanol-induced tissue damage and deleterious
post-translational modifications of the chaperone Hsp60.
Similarly, a variety of other agents and probiotics could be
tested as well using this model, which can also be used for
elucidating the cellular and molecular mechanisms underlying
the favorable effects of L. fermentum and to investigate further
the impact of Hsp60 nitration on disease progression. The
same approach could be extended to other tissues, chaper-
ones, and molecules affected by ethanol to understand how
these cellular components and their alterations participate in
ethanol-related disease, all of which will pave the way to the
development of efficacious therapies for this widespread and
devastating condition.
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Figure 8 Ethanol induced Hsp60 nitration. Representative western blots are
shown below the densitometry histogram. *Po0.05 vs. 8EtOH; ◊Po0.01 vs.
12EtOH. For the meaning of the abbreviations indicating each mouse group, see
legend for Figure 1 and Table 1. AU, arbitrary unit; Con, control; 4EtOH, ethanol-fed
mice for 4 weeks; 8EtOH, ethanol-fed mice for 8 weeks; 12EtOH, ethanol-fed mice for
12 weeks; 4EtOH-P, ethanol and probiotic-fed mice for 4 weeks; 8EtOH-P, ethanol and
probiotic-fed mice for 8 weeks; 12EtOH-P, ethanol and probiotic-fed mice for
12 weeks; 8EtOH-4P, ethanol-fed mice for 8 weeks and then given probiotic for
4 weeks; wks, weeks.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
✓ Alcohol abuse leads to alcoholic liver disease (ALD).
✓ Oxidative/nitrosative stress are identified as key elements in
the pathophysiology of ALD.
✓ Probiotics have antioxidant effects and are considered as a
promising therapeutic strategy for steatohepatitis.
WHAT IS NEW HERE
✓ A mouse model to study liver pathology caused by chronic
ethanol intake that differs from existing ones in various
ways, e.g., ethanol administration modality and inclusion of
Hsp60 as a key indicator and of a probiotic as a response
monitor. The model is fully characterized and designed to
provide information on key disease indicators and to assess
the curative efficacy of probiotics and other agents with
therapeutic potential.
✓ The probiotic L. fermentum ameliorated key disease
indicators and, as such, is also part of the model system to
be used as a positive control and as a baseline for
comparing beneficial effects when other probiotics or drugs
are evaluated.
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